Palivizumab in the prevention of respiratory syncytial virus disease

By Krilov Leonard R  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 763-769

Informa Healthcare

Access to resources Recommend Favorite

Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease

By Feltes Timothy F   Sondheimer Henry M  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1471-1480

Informa Healthcare

Access to resources Recommend Favorite

Blocking Intercellular Adhesion Molecule-1 on Human Epithelial Cells Decreases Respiratory Syncytial Virus Infection

By Behera A.K.   Matsuse H.   Kumar M.   Kong X.   Lockey R.F.   Mohapatra S.S.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 1, 2001-01 ,pp. : 188-195

Elsevier

Access to resources Recommend Favorite

Targeted Therapy of Respiratory Syncytial Virus by 2_5A Antisense

By Cramer Hagen   Okicki James   Kuang Mei   Xu Zan  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 24, Iss. 5-7, 2005-04 ,pp. : 497-501

Taylor & Francis Ltd

Access to resources Recommend Favorite

Carriers for the delivery of a vaccine against respiratory syncytial virus

By Cranage Martin   Taylor Geraldine  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 939-952

Informa Healthcare

Access to resources Recommend Favorite